Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the US: A Narrative Review of the Literature

被引:23
|
作者
Baldwin, Aleta [1 ]
Light, Brenda [2 ]
Allison, Waridibo E. [3 ]
机构
[1] Calif State Univ Sacramento, Dept Publ Hlth, Solano Hall 3014,6000 J St, Sacramento, CA 95819 USA
[2] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Div Infect Dis, Dept Med, San Antonio, TX 78229 USA
关键词
HIV prevention; Pre-exposure prophylaxis; Gender; PrEP; Cisgender women; Transgender women; HEALTH-CARE-SYSTEM; NEW-YORK; UNITED-STATES; SAFER CONCEPTION; RISK PERCEPTION; DRUG DETECTION; BLACK-WOMEN; PREVENTION; MEN; SEX;
D O I
10.1007/s10508-020-01903-8
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Using a socioecological approach, this review describes the peer-reviewed literature on oral pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender women (trans women) in the U.S. A search of the PubMed database and HIV-related conference abstracts generated over 2,200 articles and abstracts. Of these, 103 fulfilled review inclusion criteria. Most of the existing research presents findings on individual-level factors associated with PrEP use such as willingness and perceived barriers. There was far less investigation of factors related to PrEP at more distal ecological levels. Though trans women are at greater risk of HIV infection than cisgender women, less is known about this population group with respect to PrEP despite their inclusion in many major clinical trials. Further, the literature is characterized by a persistent conflation of sex and gender which makes it difficult to accurately assess the reviewed research on HIV prevention and PrEP apart from risk group. Informed by these findings, we highlight specific opportunities to improve access to PrEP and reduce socioecological barriers to PrEP care engagement for cisgender and transgender women.
引用
收藏
页码:1713 / 1728
页数:16
相关论文
共 50 条
  • [41] Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV
    Auerbach, Judith D.
    Kinsky, Suzanne
    Brown, Gina
    Charles, Vignetta
    [J]. AIDS PATIENT CARE AND STDS, 2015, 29 (02) : 102 - 110
  • [42] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
    Gaspar, Mark
    Salway, Travis
    Grace, Daniel
    [J]. SOCIAL THEORY & HEALTH, 2022, 20 (02) : 171 - 187
  • [43] HIV Pre-exposure Prophylaxis (PrEP): What is our future?
    Spornraft-Ragaller, P.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 37 - 37
  • [44] HIV Pre-Exposure Prophylaxis (PrEP)-A Quantitative Ethics Appraisal
    Kokolo, Madzouka B.
    Fergusson, Dean A.
    Cameron, D. William
    [J]. PLOS ONE, 2011, 6 (08):
  • [45] The impact of pre-exposure prophylaxis (PrEP) and screening on the dynamics of HIV
    Pinto, Carla M. A.
    Carvalho, Ana R. M.
    [J]. JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS, 2018, 339 : 231 - 244
  • [46] A secondary gendered analysis of interviews with Latina cisgender women indicated for HIV pre-exposure prophylaxis
    Lim, Sahnah
    Mantsios, Andrea
    Braithwaite, Ronald S.
    Pitts, Robert
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2024, 36 (05): : 692 - 702
  • [47] Pre-exposure Prophylaxis for Transgender People: A Systematic Review
    Perez-Alba, Eduardo
    Iquize-Condori, Roxana Claudia
    Cantu-Hernandez, Jorge Alberto
    Alvarez-Villalobos, Neri Alejandro
    Salinas-Garza, Luis Adrian
    Camacho-Ortiz, Adrian
    [J]. CLINICAL INFECTIOUS DISEASES, 2024,
  • [48] Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence
    Moore, Mia
    Stansfield, Sarah
    Donnell, Deborah J.
    Boily, Marie-Claude
    Mitchell, Kate M.
    Anderson, Peter L.
    Delany-Moretlwe, Sinead
    Bekker, Linda-Gail
    Mgodi, Nyaradzo M.
    Celum, Connie L.
    Dimitrov, Dobromir
    [J]. NATURE MEDICINE, 2023, 29 (11) : 2748 - 2752
  • [49] Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence
    Mia Moore
    Sarah Stansfield
    Deborah J. Donnell
    Marie-Claude Boily
    Kate M. Mitchell
    Peter L. Anderson
    Sinead Delany-Moretlwe
    Linda-Gail Bekker
    Nyaradzo M. Mgodi
    Connie L. Celum
    Dobromir Dimitrov
    [J]. Nature Medicine, 2023, 29 : 2748 - 2752
  • [50] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
    Mark Gaspar
    Travis Salway
    Daniel Grace
    [J]. Social Theory & Health, 2022, 20 : 171 - 187